CELJF Quote, Financials, Valuation and Earnings

Nexxen International has a net margin of 5.02% compared to Cellcom Israel's net margin of 16.12%. Cellcom Israel's return on equity of 6.52% beat Nexxen International's return on equity of 2.61%.

Cellcom Israel has a consensus price target of --, signalling downside risk potential of --. On the other hand Nexxen International has an analysts' consensus of $12.00 which suggests that it could grow by 15.5%. Given that Nexxen International has higher upside potential than Cellcom Israel, analysts believe Nexxen International is more attractive than Cellcom Israel.

Cellcom Israel has a beta of 0.982, which suggesting that the stock is 1.785% less volatile than S&P 500. In comparison Nexxen International has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Cellcom Israel has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nexxen International offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cellcom Israel pays -- of its earnings as a dividend. Nexxen International pays out -- of its earnings as a dividend.

Cellcom Israel quarterly revenues are $301.2M, which are larger than Nexxen International quarterly revenues of $90.2M. Cellcom Israel's net income of $15.1M is higher than Nexxen International's net income of $14.5M. Notably, Cellcom Israel's price-to-earnings ratio is 25.65x while Nexxen International's PE ratio is 57.72x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cellcom Israel is 0.87x versus 2.12x for Nexxen International. Usually stocks with elevated PS ratios are considered overvalued.

Perion Network has a net margin of 5.02% compared to Cellcom Israel's net margin of 2.07%. Cellcom Israel's return on equity of 6.52% beat Perion Network's return on equity of 6.59%.

Cellcom Israel has a consensus price target of --, signalling downside risk potential of --. On the other hand Perion Network has an analysts' consensus of -- which suggests that it could grow by 10.87%. Given that Perion Network has higher upside potential than Cellcom Israel, analysts believe Perion Network is more attractive than Cellcom Israel.

Cellcom Israel has a beta of 0.982, which suggesting that the stock is 1.785% less volatile than S&P 500. In comparison Perion Network has a beta of 1.459, suggesting its more volatile than the S&P 500 by 45.859%.

Cellcom Israel has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perion Network offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cellcom Israel pays -- of its earnings as a dividend. Perion Network pays out -- of its earnings as a dividend.

Cellcom Israel quarterly revenues are $301.2M, which are larger than Perion Network quarterly revenues of $102.2M. Cellcom Israel's net income of $15.1M is higher than Perion Network's net income of $2.1M. Notably, Cellcom Israel's price-to-earnings ratio is 25.65x while Perion Network's PE ratio is 9.70x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cellcom Israel is 0.87x versus 0.74x for Perion Network. Usually stocks with elevated PS ratios are considered overvalued.

Playtika Holding has a net margin of 5.02% compared to Cellcom Israel's net margin of 6.33%. Cellcom Israel's return on equity of 6.52% beat Playtika Holding's return on equity of --.

Cellcom Israel has a consensus price target of --, signalling downside risk potential of --. On the other hand Playtika Holding has an analysts' consensus of $9.80 which suggests that it could grow by 39.94%. Given that Playtika Holding has higher upside potential than Cellcom Israel, analysts believe Playtika Holding is more attractive than Cellcom Israel.

Cellcom Israel has a beta of 0.982, which suggesting that the stock is 1.785% less volatile than S&P 500. In comparison Playtika Holding has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Cellcom Israel has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Playtika Holding offers a yield of 5.71% to investors and pays a quarterly dividend of $0.10 per share. Cellcom Israel pays -- of its earnings as a dividend. Playtika Holding pays out -- of its earnings as a dividend.

Cellcom Israel quarterly revenues are $301.2M, which are smaller than Playtika Holding quarterly revenues of $620.8M. Cellcom Israel's net income of $15.1M is lower than Playtika Holding's net income of $39.3M. Notably, Cellcom Israel's price-to-earnings ratio is 25.65x while Playtika Holding's PE ratio is 12.07x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cellcom Israel is 0.87x versus 1.02x for Playtika Holding. Usually stocks with elevated PS ratios are considered overvalued.

Radcom has a net margin of 5.02% compared to Cellcom Israel's net margin of 14.23%. Cellcom Israel's return on equity of 6.52% beat Radcom's return on equity of 8.56%.

Cellcom Israel has a consensus price target of --, signalling downside risk potential of --. On the other hand Radcom has an analysts' consensus of -- which suggests that it could grow by 31.69%. Given that Radcom has higher upside potential than Cellcom Israel, analysts believe Radcom is more attractive than Cellcom Israel.

Cellcom Israel has a beta of 0.982, which suggesting that the stock is 1.785% less volatile than S&P 500. In comparison Radcom has a beta of 0.893, suggesting its less volatile than the S&P 500 by 10.678%.

Cellcom Israel has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Radcom offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cellcom Israel pays -- of its earnings as a dividend. Radcom pays out -- of its earnings as a dividend.

Cellcom Israel quarterly revenues are $301.2M, which are larger than Radcom quarterly revenues of $15.8M. Cellcom Israel's net income of $15.1M is higher than Radcom's net income of $2.3M. Notably, Cellcom Israel's price-to-earnings ratio is 25.65x while Radcom's PE ratio is 25.85x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cellcom Israel is 0.87x versus 3.27x for Radcom. Usually stocks with elevated PS ratios are considered overvalued.